Elliott, M.J
GlaxoSmithKline (United Kingdom)
3 papers on CoChat
Most cited papers
- Verified
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 1,682
- Verified
Zanamivir in the Prevention of Influenza Among Healthy Adults: A Randomized Controlled Trial
Monto, A. S., Robinson, D. P., Herlocher, M. L., Hinson, Jr., Elliott, M. J., & Crisp, A. (1999) · JAMA
Influenza Virus Research StudiesRespiratory viral infections research
Cited by 321
- Verified
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis
Cope, A. P., Londei, M., Chu, N. R., Cohen, S. B., Elliott, M. J., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · Journal of Clinical Investigation
Rheumatoid Arthritis Research and TherapiesT-cell and B-cell Immunology
Cited by 243
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free